Join

Compare · ASML vs GBS

ASML vs GBS

Side-by-side comparison of ASML Holding N.V. New York Registry Shares (ASML) and GBS Inc. (GBS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • ASML operates in Technology, while GBS operates in Industrials - the two are in different parts of the market.
  • ASML is the larger of the two at $561.82B, about 42416.3x GBS ($13.2M).
  • ASML has hit the wire 5 times in the past 4 weeks while GBS has been quiet.
  • ASML has more recent analyst coverage (25 ratings vs 0 for GBS).
MetricASMLGBS
Company
ASML Holding N.V. New York Registry Shares
GBS Inc.
Price
$1456.99+2.74%
$0.46-16.25%
Market cap
$561.82B
$13.2M
1M return
-
-
1Y return
-
-
Industry
Industrial Machinery/Components
Industrial Machinery/Components
Exchange
NASDAQ
NASDAQ
IPO
1995
2020
News (4w)
5
0
Recent ratings
25
0
ASML

ASML Holding N.V. New York Registry Shares

ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection related systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to measure the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and software solutions to create applications that enhance the setup of the lithography system; and mature products and services that refurbish used lithography equipment and offers associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, the Netherlands, Europe, the Middle East, Africa, the United States, and rest of Asia. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

GBS

GBS Inc.

GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. GBS Inc. was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.